Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DEXLANSOPRAZOLE Cause Appendicolith? 109 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 109 reports of Appendicolith have been filed in association with DEXLANSOPRAZOLE (Dexlansoprazole). This represents 0.5% of all adverse event reports for DEXLANSOPRAZOLE.

109
Reports of Appendicolith with DEXLANSOPRAZOLE
0.5%
of all DEXLANSOPRAZOLE reports
109
Deaths
94
Hospitalizations

How Dangerous Is Appendicolith From DEXLANSOPRAZOLE?

Of the 109 reports, 109 (100.0%) resulted in death, 94 (86.2%) required hospitalization, and 82 (75.2%) were considered life-threatening.

Is Appendicolith Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for DEXLANSOPRAZOLE. However, 109 reports have been filed with the FAERS database.

What Other Side Effects Does DEXLANSOPRAZOLE Cause?

Chronic kidney disease (15,973) Acute kidney injury (7,599) Renal failure (6,618) End stage renal disease (4,800) Renal injury (4,320) Tubulointerstitial nephritis (2,177) Death (1,417) Rebound acid hypersecretion (1,160) Gastrooesophageal reflux disease (1,013) Drug ineffective (859)

What Other Drugs Cause Appendicolith?

LANSOPRAZOLE (259) ONDANSETRON (259) ALLOPURINOL (258) CEFTRIAXONE (257) ALBUTEROL (256) HYDROMORPHONE (255) METRONIDAZOLE (253) SIMVASTATIN (253) ACETAMINOPHEN (252) GABAPENTIN (252)

Which DEXLANSOPRAZOLE Alternatives Have Lower Appendicolith Risk?

DEXLANSOPRAZOLE vs DEXMEDETOMIDINE DEXLANSOPRAZOLE vs DEXMETHYLPHENIDATE DEXLANSOPRAZOLE vs DEXMETHYLPHENIDATE\SERDEXMETHYLPHENIDATE DEXLANSOPRAZOLE vs DEXPANTHENOL DEXLANSOPRAZOLE vs DEXRAZOXANE

Related Pages

DEXLANSOPRAZOLE Full Profile All Appendicolith Reports All Drugs Causing Appendicolith DEXLANSOPRAZOLE Demographics